Geisinger Health System is benefiting from acquisitions and a focus on high-acuity service lines, but the group still saw its expenses outpace revenue in its fiscal first quarter.
HHS' partnership this month with OptumLabs is likely to add momentum to the push to use big data to lower healthcare costs and improve the quality of care delivery.
In 2010, Humana shelled out nearly $800 million for occupational and urgent-care provider Concentra, starting a small wave of insurers buying providers. But it turns out insurers are more interested in striking new types of contracts with providers than owning them.
New York's experiment to better coordinate care for low-income and disabled state residents who are dually eligible for Medicaid and Medicare is losing hundreds of beneficiaries.
Diabetic patients are a popular target population for health systems that hope to improve patients' health with better care coordination and closer management. But new data from the research collaborative OptumLabs suggest diabetes management can be too aggressive.
After a strong increase in net patient revenue, Geisinger Health System reported an operating margin of 3.5% for fiscal 2015, a slight uptick compared with 3.4% last year.
Dr. David Feinberg, who succeeded Dr. Glenn Steele as president and CEO of Geisinger Health System, discusses his system's genetic research program, the challenges of managing the health of Medicaid patients and how he plans to make Geisinger more patient-centered.
The Affordable Care Act's experiments in Medicare payment reform have their doubters, but investors see opportunity. Several companies have emerged to capitalize on the ACA's complex new programs designed to change how traditional Medicare spends more than $450 billion a year in payments.
Hospitals and health systems added 15,900 jobs last month, according to preliminary seasonally adjusted figures from the Bureau of Labor Statistics released last week. Hospitals created more than 100,000 jobs in the first eight months of this year alone.
Healthcare is an economic paradox. On one hand, it's our nation's fastest-growing employer, projected to add 15.6 million jobs by 2022. On the other, high costs coupled with an aging population are breaking budgets.
The hips and knees of the nation's seniors were an obvious target for Medicare's first mandatory test of an alternative payment model for hospitals. But joint replacement isn't the only possible target. Hospitals are now on notice that Medicare will move ahead if they don't do it on their own.
Hospitals and investors are banking on the U.S. Supreme Court or the states to save premium subsidies that have made health insurance affordable for 6.4 million people in 34 states. But the stocks of publicly traded hospital companies could take a big hit if that doesn't happen.